Psychiatry News and Research

RSS

Psychiatry is the treatment, study and prevention of mental disorders.

New method provides valuable insights into the brain's noradrenaline system

An international team of researchers has provided valuable insights into the brain's noradrenaline (NA) system, which has been a longtime target for medications to treat attention-deficit/hyperactivity disorder, depression, and anxiety.

24 Oct 2023

Heated yoga sessions linked to greater reductions in depressive symptoms

In a randomized controlled clinical trial of adults with moderate-to-severe depression, those who participated in heated yoga sessions experienced significantly greater reductions in depressive symptoms compared with a control group.

24 Oct 2023

Can your sleep predict depression? Insights from a genetic study

Researchers conducted a prospective study using a population-based cohort to calculate polygenic scores and understand whether suboptimal sleep durations indicated a predisposition to depression and vice versa.

24 Oct 2023

Decoding schizophrenia: insights and impacts from genetic discoveries

A recent study in Molecular Psychiatry delves into the genetic architecture of schizophrenia, uncovering insights into common and rare genetic variants, treatment resistance, and the evolutionary paradox of the disorder. This research highlights the complex nature of schizophrenia and the need for a transdiagnostic approach to psychiatric research.

22 Oct 2023

School discipline events linked to drop in GPA for Black and Latinx children

Being suspended from school or sent to the office is tied to a big drop in grade point average (GPA), especially for Black and Latinx children, according to UC San Francisco researchers.

20 Oct 2023

Pupil size may predict response to TMS treatment for depression

New findings from researchers at UCLA Health suggest that measuring changes in how pupils react to light could help predict recovery from depression and personalize transcranial magnetic stimulation (TMS) treatment of major depressive disorder.

20 Oct 2023

Clinical study evaluates safety and efficacy of methylone in patients with severe PTSD

Clerkenwell Health, the modern mental health company specializing in matching patients with cutting-edge psychiatry treatments, today announced that it is taking part in Transcend Therapeutics’ Phase 2 study evaluating the safety and efficacy of methylone in patients with severe PTSD.

20 Oct 2023

Consistent lack of sleep may raise the risk of developing depressive symptoms

Consistently sleeping less than five hours a night might raise the risk of developing depressive symptoms, according to a new genetic study led by UCL (University College London) researchers.

19 Oct 2023

Study sheds light on genetic architecture of postpartum depression

Postpartum depression (PPD), a common subtype of major depressive disorder, is more heritable than other psychiatric conditions, yet the genetics of PPD are understudied compared to these other psychiatric conditions., such as anxiety and bipolar disorder.

19 Oct 2023

How does oxidative stress during pregnancy influence the child’s behavior and emotional states?

Researchers investigate the association between maternal oxidative stress during pregnancy and early childhood mental disorders.

19 Oct 2023

How do different organ microbiomes influence neuropsychiatric disorders?

Scientists review existing literature to understand how the microbiome influences neuropsychiatric disorders.

19 Oct 2023

Prenatal exposure to EDCs linked to accelerated BMI gain in children

A new study led by researchers from the Barcelona Institute for Global Health (ISGlobal), a center supported by the "la Caixa Foundation" has shed light on the influence that Endocrine-Disrupting Chemicals (EDCs) can have on children's growth during their early years.

18 Oct 2023

Study finds disruptions in functional brain connectivity in people with schizophrenia

Schizophrenia, a neurodevelopmental disorder that features psychosis among its symptoms, is thought to arise from disorganization in brain connectivity and functional integration.

17 Oct 2023

Virtual reality therapy shows promise for treating hoarding disorder

Many people who dream of an organized, uncluttered home à la Marie Kondo find it hard to decide what to keep and what to let go. But for those with hoarding disorder -; a mental condition estimated to affect 2.5% of the U.S. population -; the reluctance to let go can reach dangerous and debilitating levels.

16 Oct 2023

Doctors abandon a diagnosis used to justify police custody deaths. It might live on, anyway.

Brooks Walsh hadn't questioned whether "excited delirium syndrome" was a legitimate medical diagnosis before the high-profile police killings of Elijah McClain in Colorado in 2019 and George Floyd in Minnesota in 2020.

16 Oct 2023

University of Kentucky selected as the nationwide coordination center for NIH racial equity initiative

The University of Kentucky has been selected as the nationwide coordination center for a National Institutes of Health (NIH) initiative. Danelle Stevens-Watkins, Ph.D., will lead the National Institute on Drug Abuse (NIDA) Racial Equity Initiative as principal investigator.

13 Oct 2023

Dementia risk factors have greater impact on minority ethnic groups

Factors that increase the risk of dementia have a greater impact on risk for people in minority ethnic groups, finds a new study led by UCL researchers.

13 Oct 2023

Study sheds new light on the relationship between autism traits and mental health in middle childhood

A long-term study by UC Davis Health researchers sheds new light on the relationship between autism traits and mental health in middle childhood.

13 Oct 2023

California bans controversial ‘excited delirium’ diagnosis

California is the first state to ban doctors and medical examiners from attributing deaths to the controversial diagnosis known as "excited delirium," which a human rights activist hailed as a "watershed moment" that could make it harder for police to justify excessive force.

12 Oct 2023